Study to Assess the Adverse Events, Tolerability, and How Oral Doses of ABBV-932 Moves Through the Body in Healthy Adult Chinese Participants
NCT07024797
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
20
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Volunteer
Interventions
DRUG:
ABBV-932
DRUG:
Placebo for ABBV-932
Sponsor
AbbVie